Featured - Neurochase

Neurochase to exhibit and present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting next month

Peter Carroll April 23, 2025 No Comments

We can confirm today (Wednesday, April 23, 2025) that Neurochase will be a first-time exhibitor at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting next month. [...]

Neurochase Appoints New Chief Marketing Officer

DuncanarioNCH March 7, 2025 No Comments

Pharmaceutical and medical device industry veteran Jacqueline Keller joins Neurochase as the company prepares to bring its pioneering CED drug delivery device for CNS indications to market – Neurochase has [...]

VIVOLTA partners with Neurochase

DuncanarioNCH November 13, 2024 No Comments

VIVOLTA partners with Neurochase to manufacture electrospun micro-catheters delivering advanced CNS therapies to the brain Waalre, The Netherlands, 13 November 2024 – VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership [...]

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

DuncanarioNCH January 18, 2024 No Comments

Original Article: Global News Wire Spark Therapeutics Enters Into Strategic Collaboration with Neurochase for Use of Proprietary Delivery Technology for CNS Disorders PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) — Spark [...]

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)

DuncanarioNCH January 18, 2024 No Comments

Innervate Therapeutics is a biotechnology company focused on developing glial cell -derived neurotrophic factor (GDNF) gene therapies to achieve neuro-restoration and neuroprotection in diseases including PD and MND. GDNF, a [...]

Brain Tumor Therapy – A New Indication For Hamlet Pharma

DuncanarioNCH January 18, 2024 No Comments

Original Article Today, Hamlet Pharma signed a joint development agreement with Neurochase Limited, founded by Professor Steven Gill, a world leading expert in the area of neurosurgery, to develop novel [...]

AviadoBio Announces Formation of Scientific Advisory Board

DuncanarioNCH January 18, 2024 No Comments

AviadoBio, a pioneering, pre-clinical stage, gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, announces that it has established a Scientific Advisory Board (SAB) [...]

Category: Featured

Neurochase to exhibit and present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting next month

Neurochase Appoints New Chief Marketing Officer

VIVOLTA partners with Neurochase

Spark Therapeutics Enters Into Strategic Collaboration with Neurochase

Novel Gene Therapy for Motor Neurone Disease (MND) & Parkinson’s (PD)

Brain Tumor Therapy – A New Indication For Hamlet Pharma

AviadoBio Announces Formation of Scientific Advisory Board